Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

Roughly 8000 Brits died from respiratory syncytial virus infections last year, with tens of thousands likely clogging up ...

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

Its symptoms are similar to those of the common cold, such as a runny nose and cough. Many people recover quickly, but RSV can lead to more severe respiratory illness in infants, young children ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Improved Bronchiolitis Symptoms: By Day 3, ziresovir-treated infants had ... provides the first solid evidence of an ...

Clinical trials have shown that the RSV vaccine reduces symptoms by around 80 per cent, significantly lowering the risk of ...

The Department of Health has announced that the jab would be more widely available as part of a wider package of preventative ...